Merkzettel Warenkorb
  • Produktbild: Pathophysiology of Heart Failure
  • Produktbild: Pathophysiology of Heart Failure
  • Produktbild: Pathophysiology of Heart Failure
Band 168

Pathophysiology of Heart Failure

Aus der Reihe Developments in Cardiovascular Medicine Band 168

146,99 €

inkl. MwSt, Versandkostenfrei

Lieferung nach Hause

Beschreibung

Details

Einband

Taschenbuch

Erscheinungsdatum

17.09.2011

Herausgeber

Naranjan S. Dhalla + weitere

Verlag

Springer Us

Seitenzahl

578

Maße (L/B/H)

23,5/15,5/3,4 cm

Gewicht

931 g

Auflage

Softcover reprint of the original 1st ed. 1996

Sprache

Englisch

ISBN

978-1-4612-8525-0

Beschreibung

Details

Einband

Taschenbuch

Erscheinungsdatum

17.09.2011

Herausgeber

Verlag

Springer Us

Seitenzahl

578

Maße (L/B/H)

23,5/15,5/3,4 cm

Gewicht

931 g

Auflage

Softcover reprint of the original 1st ed. 1996

Sprache

Englisch

ISBN

978-1-4612-8525-0

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Weitere Bände von Developments in Cardiovascular Medicine

Weitere Bände von Developments in Cardiovascular Medicine

Unsere Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Unsere Kundinnen und Kunden meinen

0 Bewertungen filtern
  • Produktbild: Pathophysiology of Heart Failure
  • Produktbild: Pathophysiology of Heart Failure
  • Produktbild: Pathophysiology of Heart Failure
  • I. Cardiomyopathy and Contractile Dysfunction.- 1. Experimental models of heart failure and cardiomyopathy.- 2. Role of tissue and circulating substance P in cardiovascular injury associated with Mg-deficiency.- 3. Functional and metabolic effects of norepinephrine on the rat heart.- 4. Interventions in experimentally induced diabetic cardiomyopathy.- 5. Diabetes as a risk factor for cardiovascular disease: Experimental models.- 6. Ethanol-induced hypertension: the role of Acetaldehyde.- 7. Abnormalities in cardiac contractile proteins and cardiac dysfunction.- 8. Role of the slow sodium channel in hereditary cardiomyopathy.- 9. Cardiac contractile failure caused by disturbances in myofibrillar energy supply and pathogenesis of cardiomyopathies.- 10. Changes in contractile proteins under oxidative stress.- 11. Antioxidants and the heart.- 12. Gene expression of cardiac myocytes: a pharmacologic target for the failing heart?.- II. Calcium-Related Events and Heart Dysfunction.- 13. Regulation of slow Ca2+ channels of myocardial cells by cyclic nucleotides and phosphorylation.- 14. Multiple roles for the membrane-associated Ca2+/calmodulin-dependent protein kinase in the regulation of sarcoplasmic reticulum function in heart muscle.- 15. Calreticulin, a multifunctional Ca2+ binding protein of smooth muscle sarcoplasmic reticulum membranes.- 16. Intracellular Ca2+ transients in response to step length changes in aequorin-injected ferret papillary muscles.- 17. Initial changes in ?-adrenergic receptor function during development of rapid ventricular pacing-induced heart failure.- 18. Impaired cellular signaling of the adenylyl cyclase and the phosphoinositide pathway in septic cardiomyopathy.- 19. Defective G-protein expression and adenylyl cyclase in genetic and experimental hypertension.- 20. Electrophysiological studies of wild-type and mutant Na+-Ca2+ exchange proteins.- 21. Cardiac sarcolemmal Na+/H+ exchange after a myocardial infarction in the rat.- 22. Myocardial Na, K-ATPase concentration and heart failure.- 23. The cytosolic calcium-force relation of vascular smooth muscle during the contraction and the relaxation.- III. Ischemia and Cellular Interactions.- 24. Ventricular remodeling following coronary artery constriction and hypertension.- 25. Collagenous proteins in scar tissue subsequent to myocardial infarction.- 26. Structural remodeling and functional changes in chronic hypoxia-induced right ventricular hypertrophy.- 27. Mechanism of openings and role of the ATP-sensitive K+ channels during myocardial ischemia/reperfusion.- 28. The contribution of K+ currents to electrical heterogeneity across the canine ventricular wall under normal and ischemic conditions.- 29. Diabetic state reduces ischemic K+ loss and H+ efflux in isolated rat hearts.- 30. Divergent effects of receptor- and nonreceptor-mediated activators of sodium-hydrogen exchange on reperfusion-induced contractile dysfunction.- 31. Heart cells in culture for studying anoxia and “simulated ischemia” at the cellular level.- 32. Cardioprotection and basic fibroblast growth factor.- 33. The heart and nitric oxide.- 34. The endothelium and the regulation of coronary blood flow.- 35. Signal transduction in vascular smooth muscle: synergistic interactions between receptors and transduction pathways.- 36. Modulation of peak aerobic capacity by the peripheral circulation during the course of the syndrome of congestive heart failure.